IGC Pharma, Inc.

IGCAMEXUSD
0.30 USD
0.01 (2.40%)AT CLOSE (11:59 AM EDT)
0.30
0.00 (0.80%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
0.30
0.00 (0.80%)
🔴Market: CLOSED

Shares of IGC Pharma, Inc. (IGC) are trading at $0.30. IGC shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Strong Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, IGC trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Aug 24, 2026.

Open?$0.31
High?$0.31
Low?$0.30
Prev. Close?$0.31
Volume?916.5K
Avg. Volume?698.6K
VWAP?$0.30
Rel. Volume?1.31x
Bid / Ask
Bid?$0.30 × 300
Ask?$0.30 × 300
Spread?$0.00
Midpoint?$0.30
Valuation & Ratios
Market Cap?31.0M
Shares Out?103.4M
Float?73.5M
Float %?74.4%
P/E Ratio?N/A
P/B Ratio?5.07
EPS?-$0.06
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Employees
70
Market Cap
31.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2006-04-13
Address
10224 FALLS ROAD
POTOMAC, MD 20854
Phone: 301-529-4996
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
10
Short Sent.?
54
Piotroski F-Score?1/9Weak
Altman Z-Score?-16.76Distress
Confidence?56%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.74%Low
Short Interest?541.7K
Days to Cover?1.7
Free Float73.5M
Avg Daily Volume322.9K
Settlement Date2026-07-31
Financial Health
Current Ratio?0.40Weak
Quick Ratio?0.18Weak
Cash Ratio?0.07Low
Debt/Equity?0.15Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A
P/B?
Peers
100
S&P
36
5.07FAIR
P/S?
Peers
100
S&P
3
23.77HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-4.7CHEAP
EV/Sales?
Peers
100
S&P
3
24.31HIGH
Returns & Efficiency
ROE?
S&P
3
-104.5%WEAK
ROA?
S&P
3
-69.6%WEAK
Cash Flow & Enterprise
FCF?$-4135000
Enterprise Value?$31.7M
Fundamentals ratios updated end of day